Atria Wealth Solutions’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,494
| Closed | -$305K | – | 1961 |
|
|
2024
Q3 | $305K | Buy |
6,494
+44
| +0.7% | +$2.07K | ﹤0.01% | 1493 |
|
|
2024
Q2 | $348K | Sell |
6,450
-1,299
| -17% | -$70.2K | ﹤0.01% | 1410 |
|
|
2024
Q1 | $528K | Buy |
7,749
+1,326
| +21% | +$90.4K | 0.01% | 1230 |
|
|
2023
Q4 | $402K | Buy |
6,423
+829
| +15% | +$51.9K | 0.01% | 1316 |
|
|
2023
Q3 | $254K | Hold |
5,594
| – | – | ﹤0.01% | 1514 |
|
|
2023
Q2 | $314K | Sell |
5,594
-4,801
| -46% | -$270K | ﹤0.01% | 1404 |
|
|
2023
Q1 | $470K | Buy |
10,395
+4,569
| +78% | +$207K | 0.01% | 1172 |
|
|
2022
Q4 | $237K | Sell |
5,826
-5,054
| -46% | -$205K | ﹤0.01% | 1494 |
|
|
2022
Q3 | $711K | Buy |
10,880
+5,111
| +89% | +$334K | 0.01% | 850 |
|
|
2022
Q2 | $351K | Buy |
+5,769
| New | +$351K | 0.01% | 1111 |
|